TickerFactsScreenerDevelopers

Korro Bio, Inc. (KRRO) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2017: -$14.61M2018: -$17.02M2019: $34.22M2020: -$45.19M2021: -$76.06M2022: -$53.65M2023: -$67.28M2024: -$60.07M2025: -$78.56M-$78.56M
2017Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$78.56M-30.8%
2024-$60.07M+10.7%
2023-$67.28M-25.4%
2022-$53.65M+29.5%
2021-$76.06M-68.3%
2020-$45.19M-232.1%
2019$34.22M+301.0%
2018-$17.02M-16.5%
2017-$14.61M—